Generated by Meeveem AI
"Advanced in-vitro diagnostics that shorten time-to-diagnosis for autoimmune and allergy testing"
AliveDx develops in-vitro diagnostic solutions that enable faster disease detection and diagnosis across autoimmune, allergy, and transfusion testing. The company's MosaiQ automated microarray platform and LumiQ immunofluorescence system deliver workflow efficiency to laboratories while reducing the time clinicians need to make critical care decisions. Healthcare professionals, laboratory teams, and patients benefit from solutions designed to improve clinical decision-making and laboratory productivity. By combining 30 years of diagnostic expertise with innovative platforms, AliveDx addresses complex diagnostic challenges for conditions including vasculitis, connective tissue diseases, and celiac disease.
400
Team Members
2007
Founded
Diagnostics
Sector
Hybrid
Work Environment
A healthcare system where diagnostic insights arrive fast enough to transform every patient's care journey and clinical outcomes.
At AliveDx, our mission is to empower diagnostic insights, transform patient care, and innovate for life.